The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.
The justices seemed by turns reluctant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.
The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.
The high court put the settlement on hold during the summer, in response to objections from the Biden administration. (AP)
Get more news: [ Ссылка ]
-------------------------------------
Join our newsletter at [ Ссылка ]
Follow us on Facebook: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
Follow us on Instagram: [ Ссылка ]
Follow us on TikTok: [ Ссылка ]
Supreme Court weighs issues in Purdue Pharma bankruptcy case
Теги
Scripps Newspurdue pharmaopioid epidemicoxycontinbidensackler familysupreme courtsupreme court hearingsupreme court argumentstop newsnews todaypurdue pharmacyPurdue Pharma bankruptcySackler family bankruptcyopioid crisisOpioidaddictionopioid addictionUS newsHarrington v. Purdue Pharmathird-party releaseThe Department of JusticebankruptcySackler Family membersthird-party releasesOral argumentsopioid deathsopioidslawsuitnews
